Physician

Howard Mandell, M.D.

According to 2025 Medicare claims, Howard Mandell, M.D. (NPI: 1316939697) practices neurology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from York, SC. This provider's primary affiliated billing organization is METROLINA NEUROLOGICAL ASSOCIATES, P A (NPI: 1124007778; TIN: 570753692) and primary practice location at 29732-1193.

Mandell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,264 traditional Medicare patients, billed 127,317 HCPCS/CPT codes, and received $2,662,856 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 8,491 prescription claims across 970 beneficiaries totaling $2,929,061 in drug costs, led by Nuplazid (Pimavanserin Tartrate). DME data shows 61 claims. Open Payments data shows 186 records totaling $116,513. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $41,582 to $6,028.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,177	32,843	$674,730
2016	2,060	39,063	$722,802
2017	2,107	57,884	$861,426
2018	1,817	56,054	$933,189
2019	1,774	42,123	$806,858
2020	1,375	35,843	$638,024
2021	1,360	27,909	$540,190
2022	1,288	30,264	$637,346
2023	1,403	50,941	$1,218,677
2024	1,264	127,317	$2,662,856

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	868	11,174	$2,678,654
2016	1,127	12,685	$3,004,981
2017	1,302	15,274	$3,972,534
2018	1,326	14,934	$4,037,800
2019	1,140	12,484	$3,909,203
2020	1,036	10,692	$3,408,986
2021	934	9,824	$3,699,978
2022	910	8,899	$3,627,642
2023	888	8,532	$3,292,744
2024	970	8,491	$2,929,061

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	67	276	$28,891
2016	103	294	$19,971
2017	37	192	$6,330
2018	88	274	$16,193
2019	86	254	$15,220
2020	41	220	$14,715
2021	11	159	$13,332
2022	N/R	134	$14,343
2023	N/R	103	$4,156
2024	N/R	61	$2,835

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	298	367	$121
70551	Mri scan of brain without contrast	134	143	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	630	769	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	305	330	$56
A9585	Injection, gadobutrol, 0.1 ml	150	12,820	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nuplazid	Pimavanserin Tartrate	66	2,760	$454,418
Austedo	Deutetrabenazine	15	450	$181,290
Kesimpta Pen	Ofatumumab	21	588	$179,471
Nurtec Odt	Rimegepant Sulfate	80	2,220	$108,831
Betaseron	Interferon Beta-1b	11	308	$107,496

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	N/R	13	$1,075
A7030	Full face mask used with positive airway pressure device, each	N	N/R	13	$1,032
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	N/R	17	$545
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	18	$182

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	164	$3,801	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	22	$112,712	UCB SA
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Howard Mandell, M.D.?

Tedicare shows public-source Medicare data for Howard Mandell, M.D. (NPI 1316939697), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Howard Mandell, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Howard Mandell, M.D.?

Howard Mandell, M.D. is linked to METROLINA NEUROLOGICAL ASSOCIATES, P A (billing NPI 1124007778) in the available physician profile data.

Does Howard Mandell, M.D. have Open Payments data?

Howard Mandell, M.D. has 186 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.